331 related articles for article (PubMed ID: 33552075)
21. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
[TBL] [Abstract][Full Text] [Related]
22. Th1 immune maturation effects of
Zhou M; Zhou S; Han K; Zhang J; Chen Q; Tian C; Zhu H; Jiang M; Min D
Sci Prog; 2022; 105(2):368504221092901. PubMed ID: 35473474
[TBL] [Abstract][Full Text] [Related]
23. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
Front Immunol; 2020; 11():574491. PubMed ID: 33193363
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN.
Kojima S; Kawana K; Tomio K; Yamashita A; Taguchi A; Miura S; Adachi K; Nagamatsu T; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Wada-Hiraike O; Yano T; Taketani Y; Fujii T; Schust DJ; Kozuma S
Am J Reprod Immunol; 2013 Feb; 69(2):134-41. PubMed ID: 23057776
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions.
Lee BN; Follen M; Tortolero-Luna G; Eriksen N; Helfgott A; Hammill H; Shearer WT; Reuben JM
Gynecol Oncol; 1999 Dec; 75(3):379-86. PubMed ID: 10600293
[TBL] [Abstract][Full Text] [Related]
26. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
27. Correlation between HPV-negative cervical lesions and cervical microenvironment.
Zheng JJ; Miao JR; Wu Q; Yu CX; Mu L; Song JH
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):855-861. PubMed ID: 33218401
[TBL] [Abstract][Full Text] [Related]
28. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
[TBL] [Abstract][Full Text] [Related]
29. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
30. [CD4 and CD8 T lymphocytes and NK cells in the stroma of the uterine cervix of women infected with human papillomavirus].
Alves DB; Tozetti IA; Gatto FA; Cassandri F; Ferreira AM; Carlos Eurico Dos Santos F; Falcão GR; Scapulatempo ID; Padovani CT; Abdo MA
Rev Soc Bras Med Trop; 2010; 43(4):425-9. PubMed ID: 20802944
[TBL] [Abstract][Full Text] [Related]
31. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
Visser J; Nijman HW; Hoogenboom BN; Jager P; van Baarle D; Schuuring E; Abdulahad W; Miedema F; van der Zee AG; Daemen T
Clin Exp Immunol; 2007 Nov; 150(2):199-209. PubMed ID: 17937675
[TBL] [Abstract][Full Text] [Related]
32. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia.
Shepherd PS; Rowe AJ; Cridland JC; Coletart T; Wilson P; Luxton JC
J Gen Virol; 1996 Apr; 77 ( Pt 4)():593-602. PubMed ID: 8627247
[TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers.
Mezache L; Paniccia B; Nyinawabera A; Nuovo GJ
Mod Pathol; 2015 Dec; 28(12):1594-602. PubMed ID: 26403783
[TBL] [Abstract][Full Text] [Related]
34. Cytokines profiles in cervical mucosa in patients with cervical high-risk human papillomavirus infection.
Long DL; Song HL; Qu PP
J Infect Dev Ctries; 2021 May; 15(5):719-725. PubMed ID: 34106897
[TBL] [Abstract][Full Text] [Related]
35. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
Sharma A; Rajappa M; Saxena A; Sharma M
Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
[TBL] [Abstract][Full Text] [Related]
36. Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
Kojima S; Kawana K; Fujii T; Yokoyama T; Miura S; Tomio K; Tomio A; Yamashita A; Adachi K; Sato H; Nagamatsu T; Schust DJ; Kozuma S; Taketani Y
Am J Reprod Immunol; 2011 Nov; 66(5):435-43. PubMed ID: 21749545
[TBL] [Abstract][Full Text] [Related]
37. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
38. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
39. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA
Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived mesenchymal stem cells inhibit CD8
Liu Z; Mi F; Han M; Tian M; Deng L; Meng N; Luo J; Fu R
Clin Exp Immunol; 2021 Jul; 205(1):53-62. PubMed ID: 33735518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
